Saw nothing but funneling money back into their private
Saw nothing but funneling money back into their private company, since they will use their patients which would put us shareholders at expense. Presenting an old paper indicates they will likely use their patent so us SHs can lose even more.
Saw a BOD that didn’t even agree with each other’s science (where is the synergy?)
I think the overall plan CytoDyn has, is to just get it for EUA and submit a BLA on OCT 15th so we could use it off label is better.
There is no reason an academic institution would steal our IP if we have it in writing that they can’t.
As SK said, there’s plenty of ways to write a contract. Right now, CytoDyn has a signed contract with an academic institution for Cancer. The others don’t even have a CEO.
Overall, I got bored and walked away with more questions that I don’t ever care to be answered.
It’s quite clear to me that they’re spreading their calls and SEC filings to put downward pressure on CytoDyns efforts.
Brazil Critical critical will be a success.
Todays PR is finally letting the world know what LONGS already knew.
“Scott Kelly to Present at the World Antiviral Congress 2021”
Slowly but surely, shorts are wrong.
“No sales in Philippines”, we are getting larger orders.
“Brazil trials won’t start”, they got approved.
“Brazil IV bag problem won’t be solved”
Then we got Critical approved.
They’re going to use “trials will take forever to fill” (even though there’s many cases a day there).
They’re going to use “those countries money situations won’t bring much revenue” but what’s funny is that Einstein has ran more Covid Trials than just about anyone. They also designed the trial with Recknor after having all the data.
The UK, Canada, US, the world is waiting.
Supply is low and Demand will be high.
22
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...
Continue Reading
Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...
Continue Reading
Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...
Continue Reading
York Space Systems: Under Legal Fire You ever hear the one about York Space Systems? Yeah, their ticker YSS is buzzing for all the wrong reasons. Not even a year out from their IPO, and already they're tangled in a class action lawsuit that's got investors with their heads in their hands. ClaimsFiler, a shareholder information outfit, just blasted out a reminder for...
Continue Reading
Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...
Continue Reading
Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...
Continue Reading
IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...
Continue Reading
LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...
Continue Reading
What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...
Continue Reading
LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...
Continue Reading
Top 5 Most Recently Viewed Articles
Growth of the Trade Finance Software Market The Trade Finance Software market is experiencing notable growth. It's anticipated to increase from a valuation of USD 8,014 million in 2023 to an impressive USD 9,893.6 million by 2030. This marks a compound annual growth rate (CAGR) of 3.1% throughout the forecast period. Key factors driving this expansion include the...
Continue Reading
Exploring the Growth of Danaher Stock Over a Decade Danaher Corporation's stock, represented by the ticker DHR, has shown remarkable prowess in the investment landscape over the last 10 years. The company has outshone the broader market with an annualized return that surpasses its competitors by 6.5%, achieving an impressive average annual return of 18.16%. With a current...
Continue Reading
ZyVersa's New Findings on NLRP3 Inflammasome and Heart Health Heart failure with preserved ejection fraction (HFpEF) poses serious health challenges globally, particularly among individuals with obesity and diabetes. The link between these conditions and HFpEF has prompted researchers to explore innovative treatments. ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA) has...
Continue Reading
Veru Inc. Prepares for Fourth Quarter Earnings Release Veru Inc. (NASDAQ: VERU) is gearing up to announce its fourth quarter earnings soon, aiming to provide shareholders with insights about its performance during this period. Analysts' Expectations for Veru's Performance Market analysts have set the expectation for the Miami-based healthcare company to report a loss of...
Continue Reading
Rivian's Expectations for Q4 Earnings As Rivian Automotive prepares to announce its fourth-quarter financial results, the spotlight will be on the company's improving profitability and the highly anticipated launch of the R2 vehicle. Analysts eagerly await this update, which is set to follow market closure. Earnings Forecast Revenue Predictions Forecasts indicate Rivian...
Continue Reading